NCT03316482View on ClinicalTrials.gov

Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 11, 2015

Primary Completion Date

August 29, 2019

Study Completion Date

December 30, 2019

Conditions
Central Precocious Puberty
Interventions
DRUG

Leuplin DPS 11.25mg

Leuplin DPS 11.25mg s.c. every 12 weeks

Trial Locations (1)

Unknown

Hwang, Jin Soon, Suwon

All Listed Sponsors
lead

Jin Soon Hwang

OTHER

NCT03316482 - Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty | Biotech Hunter | Biotech Hunter